DETAILS, FICTION AND API MANUFACTURING

“The current problem has exposed some structural weaknesses in the EU’s medicines provide chain and a significant dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides said. She suggested that supply chain concerns be resolved in an EU pharmaceutical system predicted to generally be introduced by the end on the yr.Mo